scholarly journals Preventing vaccinia virus class-I epitopes presentation by HSV-ICP47 enhances the immunogenicity of a TAP-independent cancer vaccine epitope

2012 ◽  
Vol 131 (5) ◽  
pp. E659-E669 ◽  
Author(s):  
Nermin Raafat ◽  
Charlotte Sadowski-Cron ◽  
Chantal Mengus ◽  
Michael Heberer ◽  
Giulio C. Spagnoli ◽  
...  
Keyword(s):  
Vaccinia Virus ◽  
Cancer Vaccine ◽  
Class I

Expression of Adenovirus E3/19K Protein Does Not Alter Mouse MHC Class I-Restricted Responses to Vaccinia Virus

Virology ◽  
1994 ◽  
Vol 204 (2) ◽  
pp. 558-562 ◽  
Author(s):  
Josephine H. Cox ◽  
R.Mark L. Buller ◽  
Jack R. Bennink ◽  
Jonathan W. Yewdell ◽  
Gunasegaran Karupiah
Keyword(s):  
Vaccinia Virus ◽  
Mhc Class I ◽  
Class I

High expression of MAGE-A4 and MHC class I antigens in tumor cells and induction of MAGE-A4 immune responses are prognostic markers of CHP-MAGE-A4 cancer vaccine

Vaccine ◽  
2014 ◽  
Vol 32 (45) ◽  
pp. 5901-5907 ◽  
Author(s):  
Takuro Saito ◽  
Hisashi Wada ◽  
Makoto Yamasaki ◽  
Hiroshi Miyata ◽  
Hiroyoshi Nishikawa ◽  
...  
Keyword(s):  
Immune Responses ◽  
Tumor Cells ◽  
Mhc Class I ◽  
Cancer Vaccine ◽  
Prognostic Markers ◽  
High Expression ◽  
Class I ◽  
Mhc Class I Antigens
Sign in / Sign up

Export Citation Format

Share Document